A. Berns
Impact in
- Cell Biology top 5%
- Hippo pathway signaling and YAP/TAZ
- Neurology top 5%
- Neurofibromatosis and Schwannoma Cases
Papers in
-
- Phytochemical compounds biological activities 2
- CRISPR and Genetic Engineering 2
-
- Cancer Mechanisms and Therapy 5
- Co-authors
- Jos Jonkers (1 shared paper)Marco Giovannini (4 shared papers)Martin van der Valk (3 shared papers)Gaston Habets (1 shared paper)John G. Collard (1 shared paper)Rob A. van der Kammen (1 shared paper)Jord C. Stam (1 shared paper)Paul Krimpenfort (3 shared papers)
- Journals
- Genes & Development (3 papers)ESMO Open (2 papers)Cell (1 paper)Nucleic Acids Research (1 paper)Journal of Cellular Biochemistry (1 paper)
- Partner nations
- NetherlandsUnited StatesFrance
In The Last Decade
A. Berns
17 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 84
- Cell Biology 347
- Neurology 271
- Immunology 381
- Pathology and Forensic Medicine 275
- Oncology 412
Countries citing papers authored by A. Berns
This map shows the geographic impact of A. Berns's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Berns with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Berns more than expected).
Fields of papers citing papers by A. Berns
This network shows the impact of papers produced by A. Berns. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Berns. The network helps show where A. Berns may publish in the future.
Co-authors
The 25 scholars most cited alongside A. Berns, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 446 | |
| 2 | 2000 | 300 | |
| 3 | 1997 | 204 | |
| 4 | 1996 | 156 | |
| 5 | 1997 | 139 | |
| 6 | 1997 | 134 | |
| 7 | Thymic lymphomas in interleukin 9 transgenic mice. | 1994 | 123 |
| 8 | 1999 | 105 | |
| 9 | 1995 | 94 | |
| 10 | 1987 | 71 | |
| 11 | 1993 | 66 | |
| 12 | 1991 | 40 | |
| 13 | 1996 | 35 | |
| 14 | 1972 | 15 | |
| 15 | Conditional biallelic Nf2 mutation in the mouse promotes manifestations of human neurofibromatosis type 2. | 2000 | 13 |
| 16 | Cardiac-restricted targeting of the retinoblastoma gene reveals a role for Rb in terminal cardiac differentiation and apoptosis | 2002 | 1 |
| 17 | 2018 | 1 | |
| 18 | 2018 | 1 |
About A. Berns
A. Berns is a scholar working on Molecular Biology, Pathology and Forensic Medicine, Neurology, Pulmonary and Respiratory Medicine and Oncology, having authored 18 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer Mechanisms and Therapy (5 papers), Sarcoma Diagnosis and Treatment (3 papers), Neurofibromatosis and Schwannoma Cases (3 papers), Peptidase Inhibition and Analysis (3 papers), Phytochemical compounds biological activities (2 papers), interferon and immune responses (2 papers), CRISPR and Genetic Engineering (2 papers) and Virus-based gene therapy research (2 papers). The work is most often cited by research in Cell Biology (347 citations), Neurology (271 citations), Immunology (381 citations), Pathology and Forensic Medicine (275 citations) and Oncology (412 citations). A. Berns has collaborated with scholars based in Netherlands, United States and France. Frequent co-authors include Jos Jonkers, Marco Giovannini, Martin van der Valk, Gaston Habets, John G. Collard, Rob A. van der Kammen, Jord C. Stam, Paul Krimpenfort, James M. Woodruff and Michiko Niwa‐Kawakita. Their work appears in journals such as Genes & Development, ESMO Open, Cell, Nucleic Acids Research and Journal of Cellular Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.